0001666071-24-000119.txt : 20240702 0001666071-24-000119.hdr.sgml : 20240702 20240702191205 ACCESSION NUMBER: 0001666071-24-000119 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240702 DATE AS OF CHANGE: 20240702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gupta Amit CENTRAL INDEX KEY: 0001961238 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 241097801 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] ORGANIZATION NAME: 06 Technology IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 4100 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 4100 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wk-form4_1719961919.xml FORM 4 X0508 4 2024-07-01 0 0001666071 Cardlytics, Inc. CDLX 0001961238 Gupta Amit 675 PONCE DE LEON AVENUE NE SUITE 4100 ATLANTA GA 30308 0 1 0 0 Chief Operating Officer 0 Common Stock 2024-07-01 4 M 0 14349 A 137025 D Common Stock 2024-07-02 4 S 0 7507 7.953 D 129518 D Restricted Stock Units 2024-07-01 4 M 0 14349 0 D Common Stock 14349 100447 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2024. The Reporting Person did not sell shares for any other purpose. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.85 to $8.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. /s/ Nick Lynton, Attorney-in-Fact 2024-07-02